CMG Pharmaceutical Co. Ltd (058820) — Free Cash Flow Generation Index
CMG Pharmaceutical Co. Ltd (058820) has a Free Cash Flow Generation Index of -28.51x as of December 2024. Free cash flow of ₩-8.27 Billion represents -29% of operating cash flow (₩290.09 Million). Explore CMG Pharmaceutical Co. Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
CMG Pharmaceutical Co. Ltd Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for CMG Pharmaceutical Co. Ltd across 11 annual periods. For the full cash flow conversion analysis, see CMG Pharmaceutical Co. Ltd cash conversion from operations.
Annual Free Cash Flow Generation for CMG Pharmaceutical Co. Ltd (2014–2024)
Year-by-year Free Cash Flow Generation Index for CMG Pharmaceutical Co. Ltd. Check CMG Pharmaceutical Co. Ltd (058820) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -108.44x | ₩-31.46 Billion | ₩290.09 Million | ₩31.75 Billion | ▼ -3639.2% |
| 2023 | -2.90x | ₩-11.34 Billion | ₩3.91 Billion | ₩15.25 Billion | ▼ -166.7% |
| 2022 | -1.09x | ₩-5.37 Billion | ₩4.94 Billion | ₩10.31 Billion | ▼ -464.9% |
| 2021 | 0.30x | ₩1.68 Billion | ₩5.63 Billion | ₩3.95 Billion | ▲ +113.1% |
| 2020 | -2.28x | ₩-6.71 Billion | ₩2.94 Billion | ₩9.65 Billion | ▲ +31.7% |
| 2019 | -3.33x | ₩-9.41 Billion | ₩2.82 Billion | ₩8.18 Billion | ▼ -186.1% |
| 2018 | 3.87x | ₩3.43 Billion | ₩886.78 Million | ₩2.55 Billion | ▲ +178.4% |
| 2017 | 1.39x | ₩2.71 Billion | ₩1.95 Billion | ₩760.59 Million | ▲ +3.3% |
| 2016 | 1.35x | ₩3.11 Billion | ₩2.31 Billion | ₩799.00 Million | ▼ -46.3% |
| 2015 | 2.51x | ₩6.05 Billion | ₩2.41 Billion | ₩3.64 Billion | ▼ -82.1% |
| 2014 | 14.00x | ₩10.15 Billion | ₩724.89 Million | ₩9.42 Billion | — |